Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Companion Diagnostics (CDx) Development Services Market Growth (Status and Outlook) 2022-2028

  • LP 4967749
  • 111 Pages
  • June 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Companion Diagnostics (CDx) Development Services will have significant change from previous year. According to our (LP Information) latest study, the global Companion Diagnostics (CDx) Development Services market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Companion Diagnostics (CDx) Development Services market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Companion Diagnostics (CDx) Development Services market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Companion Diagnostics (CDx) Development Services market, reaching US$ million by the year 2028. As for the Europe Companion Diagnostics (CDx) Development Services landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Companion Diagnostics (CDx) Development Services players cover Geneuity-Clinical Research Services, Interpace Biosciences, Labcorp, and Quest Diagnostics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Companion Diagnostics (CDx) Development Services market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Feasibility Studies

Assay Development

Analytical Validation

Clinical Validation

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Infectious Diseases

Neurological Disorders

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Geneuity-Clinical Research Services

Interpace Biosciences

Labcorp

Quest Diagnostics

Q² Solutions

ResearchDx

Almac Diagnostic Services

Biocartis

Cerba Research

Eurofins Scientific

MLM Medical Labs

Qiagen

BGI Genomics

MEDx Translational Medicine

Medical Biological Laboratories (MBL)

Novogene

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Companion Diagnostics (CDx) Development Services Market Size 2017-2028

2.1.2 Companion Diagnostics (CDx) Development Services Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Companion Diagnostics (CDx) Development Services Segment by Type

2.2.1 Feasibility Studies

2.2.2 Assay Development

2.2.3 Analytical Validation

2.2.4 Clinical Validation

2.2.5 Others

2.3 Companion Diagnostics (CDx) Development Services Market Size by Type

2.3.1 Companion Diagnostics (CDx) Development Services Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2017-2022)

2.4 Companion Diagnostics (CDx) Development Services Segment by Application

2.4.1 Infectious Diseases

2.4.2 Neurological Disorders

2.5 Companion Diagnostics (CDx) Development Services Market Size by Application

2.5.1 Companion Diagnostics (CDx) Development Services Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2017-2022)

3 Companion Diagnostics (CDx) Development Services Market Size by Player

3.1 Companion Diagnostics (CDx) Development Services Market Size Market Share by Players

3.1.1 Global Companion Diagnostics (CDx) Development Services Revenue by Players (2020-2022)

3.1.2 Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Players (2020-2022)

3.2 Global Companion Diagnostics (CDx) Development Services Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Companion Diagnostics (CDx) Development Services by Regions

4.1 Companion Diagnostics (CDx) Development Services Market Size by Regions (2017-2022)

4.2 Americas Companion Diagnostics (CDx) Development Services Market Size Growth (2017-2022)

4.3 APAC Companion Diagnostics (CDx) Development Services Market Size Growth (2017-2022)

4.4 Europe Companion Diagnostics (CDx) Development Services Market Size Growth (2017-2022)

4.5 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Growth (2017-2022)

5 Americas

5.1 Americas Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022)

5.2 Americas Companion Diagnostics (CDx) Development Services Market Size by Type (2017-2022)

5.3 Americas Companion Diagnostics (CDx) Development Services Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Companion Diagnostics (CDx) Development Services Market Size by Region (2017-2022)

6.2 APAC Companion Diagnostics (CDx) Development Services Market Size by Type (2017-2022)

6.3 APAC Companion Diagnostics (CDx) Development Services Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Companion Diagnostics (CDx) Development Services by Country (2017-2022)

7.2 Europe Companion Diagnostics (CDx) Development Services Market Size by Type (2017-2022)

7.3 Europe Companion Diagnostics (CDx) Development Services Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Companion Diagnostics (CDx) Development Services by Region (2017-2022)

8.2 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Type (2017-2022)

8.3 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Companion Diagnostics (CDx) Development Services Market Forecast

10.1 Global Companion Diagnostics (CDx) Development Services Forecast by Regions (2023-2028)

10.1.1 Global Companion Diagnostics (CDx) Development Services Forecast by Regions (2023-2028)

10.1.2 Americas Companion Diagnostics (CDx) Development Services Forecast

10.1.3 APAC Companion Diagnostics (CDx) Development Services Forecast

10.1.4 Europe Companion Diagnostics (CDx) Development Services Forecast

10.1.5 Middle East & Africa Companion Diagnostics (CDx) Development Services Forecast

10.2 Americas Companion Diagnostics (CDx) Development Services Forecast by Country (2023-2028)

10.2.1 United States Companion Diagnostics (CDx) Development Services Market Forecast

10.2.2 Canada Companion Diagnostics (CDx) Development Services Market Forecast

10.2.3 Mexico Companion Diagnostics (CDx) Development Services Market Forecast

10.2.4 Brazil Companion Diagnostics (CDx) Development Services Market Forecast

10.3 APAC Companion Diagnostics (CDx) Development Services Forecast by Region (2023-2028)

10.3.1 China Companion Diagnostics (CDx) Development Services Market Forecast

10.3.2 Japan Companion Diagnostics (CDx) Development Services Market Forecast

10.3.3 Korea Companion Diagnostics (CDx) Development Services Market Forecast

10.3.4 Southeast Asia Companion Diagnostics (CDx) Development Services Market Forecast

10.3.5 India Companion Diagnostics (CDx) Development Services Market Forecast

10.3.6 Australia Companion Diagnostics (CDx) Development Services Market Forecast

10.4 Europe Companion Diagnostics (CDx) Development Services Forecast by Country (2023-2028)

10.4.1 Germany Companion Diagnostics (CDx) Development Services Market Forecast

10.4.2 France Companion Diagnostics (CDx) Development Services Market Forecast

10.4.3 UK Companion Diagnostics (CDx) Development Services Market Forecast

10.4.4 Italy Companion Diagnostics (CDx) Development Services Market Forecast

10.4.5 Russia Companion Diagnostics (CDx) Development Services Market Forecast

10.5 Middle East & Africa Companion Diagnostics (CDx) Development Services Forecast by Region (2023-2028)

10.5.1 Egypt Companion Diagnostics (CDx) Development Services Market Forecast

10.5.2 South Africa Companion Diagnostics (CDx) Development Services Market Forecast

10.5.3 Israel Companion Diagnostics (CDx) Development Services Market Forecast

10.5.4 Turkey Companion Diagnostics (CDx) Development Services Market Forecast

10.5.5 GCC Countries Companion Diagnostics (CDx) Development Services Market Forecast

10.6 Global Companion Diagnostics (CDx) Development Services Forecast by Type (2023-2028)

10.7 Global Companion Diagnostics (CDx) Development Services Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Geneuity-Clinical Research Services

11.1.1 Geneuity-Clinical Research Services Company Information

11.1.2 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product Offered

11.1.3 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Geneuity-Clinical Research Services Main Business Overview

11.1.5 Geneuity-Clinical Research Services Latest Developments

11.2 Interpace Biosciences

11.2.1 Interpace Biosciences Company Information

11.2.2 Interpace Biosciences Companion Diagnostics (CDx) Development Services Product Offered

11.2.3 Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Interpace Biosciences Main Business Overview

11.2.5 Interpace Biosciences Latest Developments

11.3 Labcorp

11.3.1 Labcorp Company Information

11.3.2 Labcorp Companion Diagnostics (CDx) Development Services Product Offered

11.3.3 Labcorp Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Labcorp Main Business Overview

11.3.5 Labcorp Latest Developments

11.4 Quest Diagnostics

11.4.1 Quest Diagnostics Company Information

11.4.2 Quest Diagnostics Companion Diagnostics (CDx) Development Services Product Offered

11.4.3 Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Quest Diagnostics Main Business Overview

11.4.5 Quest Diagnostics Latest Developments

11.5 Q² Solutions

11.5.1 Q² Solutions Company Information

11.5.2 Q² Solutions Companion Diagnostics (CDx) Development Services Product Offered

11.5.3 Q² Solutions Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Q² Solutions Main Business Overview

11.5.5 Q² Solutions Latest Developments

11.6 ResearchDx

11.6.1 ResearchDx Company Information

11.6.2 ResearchDx Companion Diagnostics (CDx) Development Services Product Offered

11.6.3 ResearchDx Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 ResearchDx Main Business Overview

11.6.5 ResearchDx Latest Developments

11.7 Almac Diagnostic Services

11.7.1 Almac Diagnostic Services Company Information

11.7.2 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product Offered

11.7.3 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Almac Diagnostic Services Main Business Overview

11.7.5 Almac Diagnostic Services Latest Developments

11.8 Biocartis

11.8.1 Biocartis Company Information

11.8.2 Biocartis Companion Diagnostics (CDx) Development Services Product Offered

11.8.3 Biocartis Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Biocartis Main Business Overview

11.8.5 Biocartis Latest Developments

11.9 Cerba Research

11.9.1 Cerba Research Company Information

11.9.2 Cerba Research Companion Diagnostics (CDx) Development Services Product Offered

11.9.3 Cerba Research Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Cerba Research Main Business Overview

11.9.5 Cerba Research Latest Developments

11.10 Eurofins Scientific

11.10.1 Eurofins Scientific Company Information

11.10.2 Eurofins Scientific Companion Diagnostics (CDx) Development Services Product Offered

11.10.3 Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Eurofins Scientific Main Business Overview

11.10.5 Eurofins Scientific Latest Developments

11.11 MLM Medical Labs

11.11.1 MLM Medical Labs Company Information

11.11.2 MLM Medical Labs Companion Diagnostics (CDx) Development Services Product Offered

11.11.3 MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 MLM Medical Labs Main Business Overview

11.11.5 MLM Medical Labs Latest Developments

11.12 Qiagen

11.12.1 Qiagen Company Information

11.12.2 Qiagen Companion Diagnostics (CDx) Development Services Product Offered

11.12.3 Qiagen Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Qiagen Main Business Overview

11.12.5 Qiagen Latest Developments

11.13 BGI Genomics

11.13.1 BGI Genomics Company Information

11.13.2 BGI Genomics Companion Diagnostics (CDx) Development Services Product Offered

11.13.3 BGI Genomics Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 BGI Genomics Main Business Overview

11.13.5 BGI Genomics Latest Developments

11.14 MEDx Translational Medicine

11.14.1 MEDx Translational Medicine Company Information

11.14.2 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product Offered

11.14.3 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 MEDx Translational Medicine Main Business Overview

11.14.5 MEDx Translational Medicine Latest Developments

11.15 Medical Biological Laboratories (MBL)

11.15.1 Medical Biological Laboratories (MBL) Company Information

11.15.2 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product Offered

11.15.3 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Medical Biological Laboratories (MBL) Main Business Overview

11.15.5 Medical Biological Laboratories (MBL) Latest Developments

11.16 Novogene

11.16.1 Novogene Company Information

11.16.2 Novogene Companion Diagnostics (CDx) Development Services Product Offered

11.16.3 Novogene Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Novogene Main Business Overview

11.16.5 Novogene Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Companion Diagnostics (CDx) Development Services Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Feasibility Studies

Table 3. Major Players of Assay Development

Table 4. Major Players of Analytical Validation

Table 5. Major Players of Clinical Validation

Table 6. Major Players of Others

Table 7. Companion Diagnostics (CDx) Development Services Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Companion Diagnostics (CDx) Development Services Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2017-2022)

Table 10. Companion Diagnostics (CDx) Development Services Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Companion Diagnostics (CDx) Development Services Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2017-2022)

Table 13. Global Companion Diagnostics (CDx) Development Services Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Player (2020-2022)

Table 15. Companion Diagnostics (CDx) Development Services Key Players Head office and Products Offered

Table 16. Companion Diagnostics (CDx) Development Services Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Companion Diagnostics (CDx) Development Services Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Regions (2017-2022)

Table 21. Americas Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Companion Diagnostics (CDx) Development Services Market Size Market Share by Country (2017-2022)

Table 23. Americas Companion Diagnostics (CDx) Development Services Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2017-2022)

Table 25. Americas Companion Diagnostics (CDx) Development Services Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2017-2022)

Table 27. APAC Companion Diagnostics (CDx) Development Services Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Region (2017-2022)

Table 29. APAC Companion Diagnostics (CDx) Development Services Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2017-2022)

Table 31. APAC Companion Diagnostics (CDx) Development Services Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2017-2022)

Table 33. Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Country (2017-2022)

Table 35. Europe Companion Diagnostics (CDx) Development Services Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2017-2022)

Table 37. Europe Companion Diagnostics (CDx) Development Services Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Companion Diagnostics (CDx) Development Services

Table 46. Key Market Challenges & Risks of Companion Diagnostics (CDx) Development Services

Table 47. Key Industry Trends of Companion Diagnostics (CDx) Development Services

Table 48. Global Companion Diagnostics (CDx) Development Services Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Companion Diagnostics (CDx) Development Services Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Companion Diagnostics (CDx) Development Services Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Companion Diagnostics (CDx) Development Services Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Companion Diagnostics (CDx) Development Services Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Companion Diagnostics (CDx) Development Services Market Size Market Share Forecast by Application (2023-2028)

Table 54. Geneuity-Clinical Research Services Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors

Table 55. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product Offered

Table 56. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Geneuity-Clinical Research Services Main Business

Table 58. Geneuity-Clinical Research Services Latest Developments

Table 59. Interpace Biosciences Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors

Table 60. Interpace Biosciences Companion Diagnostics (CDx) Development Services Product Offered

Table 61. Interpace Biosciences Main Business

Table 62. Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Interpace Biosciences Latest Developments

Table 64. Labcorp Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors

Table 65. Labcorp Companion Diagnostics (CDx) Development Services Product Offered

Table 66. Labcorp Main Business

Table 67. Labcorp Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Labcorp Latest Developments

Table 69. Quest Diagnostics Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors

Table 70. Quest Diagnostics Companion Diagnostics (CDx) Development Services Product Offered

Table 71. Quest Diagnostics Main Business

Table 72. Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Quest Diagnostics Latest Developments

Table 74. Q² Solutions Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors

Table 75. Q² Solutions Companion Diagnostics (CDx) Development Services Product Offered

Table 76. Q² Solutions Main Business

Table 77. Q² Solutions Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Q² Solutions Latest Developments

Table 79. ResearchDx Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors

Table 80. ResearchDx Companion Diagnostics (CDx) Development Services Product Offered

Table 81. ResearchDx Main Business

Table 82. ResearchDx Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. ResearchDx Latest Developments

Table 84. Almac Diagnostic Services Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors

Table 85. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product Offered

Table 86. Almac Diagnostic Services Main Business

Table 87. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Almac Diagnostic Services Latest Developments

Table 89. Biocartis Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors

Table 90. Biocartis Companion Diagnostics (CDx) Development Services Product Offered

Table 91. Biocartis Main Business

Table 92. Biocartis Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Biocartis Latest Developments

Table 94. Cerba Research Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors

Table 95. Cerba Research Companion Diagnostics (CDx) Development Services Product Offered

Table 96. Cerba Research Main Business

Table 97. Cerba Research Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Cerba Research Latest Developments

Table 99. Eurofins Scientific Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors

Table 100. Eurofins Scientific Companion Diagnostics (CDx) Development Services Product Offered

Table 101. Eurofins Scientific Main Business

Table 102. Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. Eurofins Scientific Latest Developments

Table 104. MLM Medical Labs Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors

Table 105. MLM Medical Labs Companion Diagnostics (CDx) Development Services Product Offered

Table 106. MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 107. MLM Medical Labs Main Business

Table 108. MLM Medical Labs Latest Developments

Table 109. Qiagen Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors

Table 110. Qiagen Companion Diagnostics (CDx) Development Services Product Offered

Table 111. Qiagen Main Business

Table 112. Qiagen Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 113. Qiagen Latest Developments

Table 114. BGI Genomics Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors

Table 115. BGI Genomics Companion Diagnostics (CDx) Development Services Product Offered

Table 116. BGI Genomics Main Business

Table 117. BGI Genomics Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 118. BGI Genomics Latest Developments

Table 119. MEDx Translational Medicine Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors

Table 120. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product Offered

Table 121. MEDx Translational Medicine Main Business

Table 122. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 123. MEDx Translational Medicine Latest Developments

Table 124. Medical Biological Laboratories (MBL) Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors

Table 125. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product Offered

Table 126. Medical Biological Laboratories (MBL) Main Business

Table 127. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 128. Medical Biological Laboratories (MBL) Latest Developments

Table 129. Novogene Details, Company Type, Companion Diagnostics (CDx) Development Services Area Served and Its Competitors

Table 130. Novogene Companion Diagnostics (CDx) Development Services Product Offered

Table 131. Novogene Main Business

Table 132. Novogene Companion Diagnostics (CDx) Development Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 133. Novogene Latest Developments

List of Figures

Figure 1. Companion Diagnostics (CDx) Development Services Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Companion Diagnostics (CDx) Development Services Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Type in 2021

Figure 7. Companion Diagnostics (CDx) Development Services in Infectious Diseases

Figure 8. Global Companion Diagnostics (CDx) Development Services Market: Infectious Diseases (2017-2022) & ($ Millions)

Figure 9. Companion Diagnostics (CDx) Development Services in Neurological Disorders

Figure 10. Global Companion Diagnostics (CDx) Development Services Market: Neurological Disorders (2017-2022) & ($ Millions)

Figure 11. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Application in 2021

Figure 12. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Player in 2021

Figure 13. Global Companion Diagnostics (CDx) Development Services Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Companion Diagnostics (CDx) Development Services Market Size 2017-2022 ($ Millions)

Figure 15. APAC Companion Diagnostics (CDx) Development Services Market Size 2017-2022 ($ Millions)

Figure 16. Europe Companion Diagnostics (CDx) Development Services Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size 2017-2022 ($ Millions)

Figure 18. Americas Companion Diagnostics (CDx) Development Services Value Market Share by Country in 2021

Figure 19. Americas Companion Diagnostics (CDx) Development Services Consumption Market Share by Type in 2021

Figure 20. Americas Companion Diagnostics (CDx) Development Services Market Size Market Share by Application in 2021

Figure 21. United States Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Region in 2021

Figure 26. APAC Companion Diagnostics (CDx) Development Services Market Size Market Share by Application in 2021

Figure 27. China Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Country in 2021

Figure 34. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Type in 2021

Figure 35. Europe Companion Diagnostics (CDx) Development Services Market Size Market Share by Application in 2021

Figure 36. Germany Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Market Share by Application in 2021

Figure 44. Egypt Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Companion Diagnostics (CDx) Development Services Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 50. APAC Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 51. Europe Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 53. United States Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 54. Canada Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 57. China Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 58. Japan Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 59. Korea Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 61. India Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 62. Australia Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 63. Germany Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 64. France Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 65. UK Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 66. Italy Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 67. Russia Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 68. Spain Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 71. Israel Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Companion Diagnostics (CDx) Development Services Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450